Funding rounds/Alentis Therapeutics

Alentis Therapeutics

Series A

Basel, SwitzerlandMar 2019

Amount raised

€11M

€10,750,000

Native amount

12,500,000 CHF

Stage

Series A

series a

Investors

Provenance & confidence

High confidence

Amount

12,500,000 CHF

ECB-at-date → €11M · rate 1.1181 on 2019-03-29

stored → €11M

High confidence

Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Date

Mar 2019

Round type

series a

Amount (EUR)

€11M

same company

This is the company's only recorded round.